Data search


search
Exact
Search

Results for MligTC455_18788

Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Annotation
MligTC455_18788 27 0.57 Mlig455_040989, Mlig455_040991

Neo: -

Age: -

Mlig455_040989 {REF} {Length: 1277} {RNA1509_56938} {RNA1310_39299} {RNA815_53904}

Mlig455_040991 {REF} {Length: 1852} {RNA1509_56938} {RNA1310_34736} {RNA815_16785.1}

Cumulative graph for MligTC455_18788

Region-enriched expression

Region logFC logCPM Pvalue FDR Specificity
RegionR1 0.244 1.043 0.99971 1.00000
RegionR2 0.292 1.043 0.71310 1.00000
RegionR3 0.581 1.043 0.58303 1.00000
RegionR4 1.513 1.043 0.36434 0.68755
RegionR5 0.959 1.043 0.41783 0.77753
RegionR6 0.426 1.043 0.63867 1.00000
RegionR7 -2.11 1.043 0.99985 1.00000
RegionR8 -1.906 1.043 0.99983 1.00000

Regeneration-enriched expression

Region logFC logCPM PValue FDR Specificity
RegenerationR1 -1.73 1.043 0.99991 1.00000
RegenerationR2 -0.589 1.043 0.61985 0.92329
RegenerationR3 0.669 1.043 0.72559 0.95640
RegenerationR4 0.279 1.043 0.93424 1.00000
RegenerationR5 0.381 1.043 0.83123 0.99795
RegenerationR6 0.825 1.043 0.60351 0.87020
RegenerationBL 4.041 1.043 0.03611 0.21431
RegenerationTP -0.803 1.043 0.99987 1.00000


Genes with expression patterns similar to MligTC455_18788

Nr. Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Σ Spearman correlations Int1 Int2 Int3 Reg1 Reg2 Reg3 Annotation
1. MligTC455_18788 27 0.57 Mlig455_040989, Mlig455_040991

Neo: -

Age: -

5 1.000 - 1.000 1.000 1.000 1.000

Mlig455_040989 {REF} {Length: 1277} {RNA1509_56938} {RNA1310_39299} {RNA815_53904}

Mlig455_040991 {REF} {Length: 1852} {RNA1509_56938} {RNA1310_34736} {RNA815_16785.1}
2. MligTC455_12355 27 0.56 Mlig455_024618

Neo: -

Age: -

CHRNA3 1 - - 1.000 - - - Mlig455_024618 {REF} {Length: 2865} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=270.1]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=246.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [RH, Score=432, Expect=7e-146]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [RH, Score=432, Expect=5e-146]; ENSG00000117971, CHRNB4, cholinergic receptor nicotinic beta 4 subunit, [RH, Score=419, Expect=1e-140]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [RH, Score=427, Expect=6e-144]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [RH, Score=426, Expect=2e-143]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [RH, Score=418, Expect=1e-140]; ENSMUSG00000035200, Chrnb4, cholinergic receptor, nicotinic, beta polypeptide 4, [RH, Score=406, Expect=4e-136]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [RH, Score=524, Expect=0.0]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=459, Expect=4e-157]} {Smed: dd_Smed_v6_14630_0_1, dd_Smed_v6_14630_0_1, [RH, Score=521, Expect=6e-180]} {RNA1509_36802} {RNA1310_50512} {RNA815_3014.1}
3. MligTC455_12438 17 0.35 Mlig455_009594

Neo: -

Age: -

1 - - 1.000 - - - Mlig455_009594 {REF} {Length: 2044} {RNA1310_39190} {RNA815_29274}
4. MligTC455_13493 28 0.58 Mlig455_020299

Neo: -

Age: -

1 - - 1.000 - - - Mlig455_020299 {REF} {Length: 568} {RNA1310_11315} {RNA815_53929}
5. MligTC455_15134 15 0.31 Mlig455_000804

Neo: -

Age: -

CNGA3 1 - - 1.000 - - - Mlig455_000804 {REF} {Length: 2294} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=62.8]; Ion transport protein [PF00520.33, score=39.4]} {Human: ENSG00000144191, CNGA3, cyclic nucleotide gated channel alpha 3, [Score=351, Expect=2e-113]; ENSG00000198515, CNGA1, cyclic nucleotide gated channel alpha 1, [Score=344, Expect=2e-110]; ENSG00000183862, CNGA2, cyclic nucleotide gated channel alpha 2, [Score=340, Expect=2e-109]} {Mouse: ENSMUSG00000026114, Cnga3, cyclic nucleotide gated channel alpha 3, [Score=352, Expect=9e-115]; ENSMUSG00000067220, Cnga1, cyclic nucleotide gated channel alpha 1, [Score=342, Expect=7e-110]; ENSMUSG00000005864, Cnga2, cyclic nucleotide gated channel alpha 2, [Score=338, Expect=9e-109]} {Dmel: FBgn0259145, CG42260, [Score=463, Expect=1e-153]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [Score=281, Expect=1e-86]} {Smed: dd_Smed_v6_22398_0_1, dd_Smed_v6_22398_0_1, [Score=343, Expect=2e-111]} {RNA1310_120793} {RNA815_25814}
6. MligTC455_15160 11 0.23 Mlig455_024917

Neo: -

Age: -

1 - - 1.000 - - - Mlig455_024917 {REF} {Length: 773} {TRANSSPLICED} {RNA1310_98042}
7. MligTC455_36252 20 0.42 Mlig455_050668

Neo: -

Age: -

PRKAR2B 1 - - 1.000 - - - Mlig455_050668 {REF} {Length: 1234} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=45.2]} {Human: ENSG00000284096, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=93.2, Expect=9e-21]; ENSG00000005249, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=93.2, Expect=9e-21]} {Mouse: ENSMUSG00000002997, Prkar2b, protein kinase, cAMP dependent regulatory, type II beta, [Score=93.2, Expect=7e-21]} {Dmel: FBgn0022382, Pka-R2, Protein kinase, cAMP-dependent, regulatory subunit type 2, [Score=96.3, Expect=3e-22]} {Smed: dd_Smed_v6_1362_0_1, dd_Smed_v6_1362_0_1, [Score=87.8, Expect=2e-19]}
8. MligTC455_54226 52 1.09 Mlig455_037435, Mlig455_037458

Neo: -

Age: -

NETO2 1 - - 1.000 - - -

Mlig455_037435 {REF} {Length: 2663} {Pfam: CUB domain [PF00431.22, score=52.2]; Low-density lipoprotein receptor domain class A [PF00057.20, score=31.7]} {Human: ENSG00000171208, NETO2, neuropilin and tolloid like 2, [Score=96.3, Expect=3e-20]} {Mouse: ENSMUSG00000036902, Neto2, neuropilin (NRP) and tolloid (TLL)-like 2, [Score=97.8, Expect=6e-21]} {Dmel: FBgn0265416, Neto, Neuropilin and tolloid-like, [Score=87.8, Expect=1e-17]} {Celegans: WBGene00019360, neto-1, NETO (NEuropilin and TOlloid-like) homolog, [Score=77.4, Expect=4e-15]} {Smed: dd_Smed_v6_8579_0_1, dd_Smed_v6_8579_0_1, [Score=87.0, Expect=1e-17]} {RNA1310_38111}

Mlig455_037458 {REF} {Length: 2349} {Pfam: CUB domain [PF00431.22, score=52.1]; Low-density lipoprotein receptor domain class A [PF00057.20, score=31.7]} {Human: ENSG00000171208, NETO2, neuropilin and tolloid like 2, [RH, Score=144, Expect=9e-37]} {Mouse: ENSMUSG00000036902, Neto2, neuropilin (NRP) and tolloid (TLL)-like 2, [RH, Score=146, Expect=1e-37]} {Dmel: FBgn0265416, Neto, Neuropilin and tolloid-like, [Score=117, Expect=2e-27]} {Celegans: WBGene00019360, neto-1, NETO (NEuropilin and TOlloid-like) homolog, [Score=105, Expect=1e-24]} {Smed: dd_Smed_v6_8579_0_1, dd_Smed_v6_8579_0_1, [Score=115, Expect=6e-27]} {RNA1310_38111}
9. MligTC455_05874 5 0.11 Mlig455_049976

Neo: -

Age: -

0.998 - - 0.998 - - - Mlig455_049976 {REF} {Length: 389} {TRANSSPLICED} {NoTransDecoderORF} {RNA1310_109621}
10. MligTC455_41475 43 0.89 Mlig455_021663, Mlig455_021712

Neo: -

Age: -

0.998 - - 0.998 - - -

Mlig455_021663 {REF} {Length: 486} {NoTransDecoderORF} {RNA1310_96898}

Mlig455_021712 {REF} {Length: 812} {NoTransDecoderORF} {RNA1310_96898}
11. MligTC455_49949 46 0.95 Mlig455_069056

Neo: -

Age: -

ASIC1 0.998 - - 0.998 - - - Mlig455_069056 {REF} {Length: 2381} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=204.6]} {Human: ENSG00000110881, ASIC1, acid sensing ion channel subunit 1, [Score=58.5, Expect=3e-08]} {Mouse: ENSMUSG00000023017, Asic1, acid-sensing (proton-gated) ion channel 1, [Score=58.2, Expect=2e-08]; ENSMUSG00000028008, Asic5, acid-sensing (proton-gated) ion channel family member 5, [Score=57.4, Expect=4e-08]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=76.6, Expect=2e-14]} {Smed: dd_Smed_v6_12037_0_1, dd_Smed_v6_12037_0_1, [Score=94.4, Expect=4e-20]} {RNA1509_44792} {RNA1310_8631} {RNA815_5782}
12. MligTC455_08407 22 0.46 Mlig455_043162

Neo: -

Age: -

0.991 - - 0.991 - - - Mlig455_043162 {REF} {Length: 1257} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=20.7]} {RNA1310_58288} {RNA815_55196}
13. MligTC455_10386 40 0.84 Mlig455_016460, Mlig455_016526, Mlig455_049813

Neo: -

Age: Up-Down-Down

CHRNA2, CHRNA6 0.989 - - 0.989 - - -

Mlig455_016460 {REF} {Length: 2441} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=156.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=111.5]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=211, Expect=9e-61]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=209, Expect=4e-60]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=201, Expect=5e-56]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=214, Expect=3e-62]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=211, Expect=1e-60]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=216, Expect=6e-63]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=210, Expect=8e-61]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [RH, Score=439, Expect=5e-148]} {RNA1310_41035} {RNA815_43177}

Mlig455_016526 {REF} {Length: 2438} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=156.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=111.5]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=211, Expect=8e-61]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=209, Expect=4e-60]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=201, Expect=6e-56]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=214, Expect=4e-62]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=211, Expect=1e-60]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=216, Expect=6e-63]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=210, Expect=8e-61]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [RH, Score=439, Expect=4e-148]} {RNA1310_41035} {RNA815_43177}

Mlig455_049813 {REF} {Length: 2457} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=156.5]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=109.6]} {Human: ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=209, Expect=5e-60]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=207, Expect=1e-59]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=6e-57]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=3e-57]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=5e-57]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=201, Expect=6e-56]} {Mouse: ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=213, Expect=1e-61]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=212, Expect=1e-61]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=204, Expect=2e-58]; ENSMUSG00000027577, Chrna4, cholinergic receptor, nicotinic, alpha polypeptide 4, [Score=203, Expect=6e-57]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=217, Expect=4e-63]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=209, Expect=1e-60]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [RH, Score=439, Expect=3e-148]} {RNA1310_41035} {RNA815_43177}
14. MligTC455_00524 6 0.12 Mlig455_035116

Neo: -

Age: -

0.988 - - 0.988 - - - Mlig455_035116 {REF} {Length: 886} {NoTransDecoderORF}
15. MligTC455_11476 26 0.54 Mlig455_035212

Neo: -

Age: -

0.988 - - 0.988 - - - Mlig455_035212 {REF} {Length: 1374} {RNA1310_88897} {RNA815_51066}
16. MligTC455_39681 136 2.83 Mlig455_045908, Mlig455_045958, Mlig455_063327

Neo: -

Age: Down-Down-Down, logFC(26M/2M)=-0.624

Region-enriched R2: 4.082/0.00717
Region-enriched R8: 3.863/0.01304

CASP1, CASP7 0.988 - - 0.988 - - -

Mlig455_045908 {REF} {Length: 1556} {NoTransDecoderORF} {RNA1310_115705} {RNA815_46116}

Mlig455_045958 {REF} {Length: 1362} {Pfam: Caspase domain [PF00656.24, score=68.0]} {Human: ENSG00000165806, CASP7, caspase 7, [Score=57.8, Expect=3e-09]} {Mouse: ENSMUSG00000025076, Casp7, caspase 7, [Score=58.9, Expect=1e-09]} {Dmel: FBgn0019972, Drice, Death related ICE-like caspase, [Score=53.1, Expect=6e-08]} {Smed: dd_Smed_v6_1167_0_1, dd_Smed_v6_1167_0_1, [Score=49.7, Expect=4e-07]} {RNA1310_50397} {RNA815_46116}

Mlig455_063327 {REF} {Length: 3941} {Pfam: Caspase domain [PF00656.24, score=81.3]} {Human: ENSG00000137752, CASP1, caspase 1, [Score=79.7, Expect=1e-15]} {Mouse: ENSMUSG00000025888, Casp1, caspase 1, [Score=82.8, Expect=1e-16]} {Dmel: FBgn0019972, Drice, Death related ICE-like caspase, [Score=63.2, Expect=2e-10]} {Celegans: WBGene00000417, ced-3, Cell death protein 3 Cell death protein 3 subunit 1 Cell death protein 3 subunit 2, [Score=75.9, Expect=6e-15]} {Smed: dd_Smed_v6_1167_0_1, dd_Smed_v6_1167_0_1, [Score=73.9, Expect=1e-14]} {RNA1509_50041} {RNA1310_2539.1} {RNA815_252.1}
17. MligTC455_27078 22 0.46 Mlig455_028337, Mlig455_066176

Neo: -

Age: -

0.987 - - 0.987 - - -

Mlig455_028337 {REF} {Length: 887} {NoTransDecoderORF} {RNA1509_59553} {RNA1310_69307} {RNA815_55083}

Mlig455_066176 {REF} {Length: 883} {NoTransDecoderORF} {RNA1509_59553} {RNA1310_69307} {RNA815_55083}
18. MligTC455_33913 32 0.66 Mlig455_047326

Neo: -

Age: -

SPON1 0.986 - - 0.986 - - - Mlig455_047326 {REF} {Length: 2405} {Pfam: Spondin_N [PF06468.15, score=98.6]} {Human: ENSG00000262655, SPON1, spondin 1, [Score=117, Expect=1e-27]} {Mouse: ENSMUSG00000038156, Spon1, spondin 1, (f-spondin) extracellular matrix protein, [Score=115, Expect=4e-27]} {Dmel: FBgn0033710, CG17739, [Score=105, Expect=3e-24]} {Celegans: WBGene00006893, spon-1, SPONdin (Extracellular matrix glycoprotein) family, [Score=83.6, Expect=5e-17]} {Smed: dd_Smed_v6_2400_0_1, dd_Smed_v6_2400_0_1, [Score=83.6, Expect=4e-17]} {RNA1509_30850} {RNA1310_29306} {RNA815_50316}
19. MligTC455_37794 20 0.42 Mlig455_017854, Mlig455_047876

Neo: -

Age: -

0.986 - - 0.986 - - -

Mlig455_017854 {REF} {Length: 3779} {NoTransDecoderORF} {RNA1509_51255} {RNA1310_84895} {RNA815_39433}

Mlig455_047876 {REF} {Length: 3089} {NoTransDecoderORF} {RNA1310_84895}
20. MligTC455_24197 48 1 Mlig455_062645

Neo: -

Age: -

KCNH7 0.981 - - 0.981 - - - Mlig455_062645 {REF} {Length: 4615} {Pfam: Ion transport protein [PF00520.33, score=125.5]; Cyclic nucleotide-binding domain [PF00027.31, score=51.0]; Ion channel [PF07885.18, score=45.8]} {Human: ENSG00000184611, KCNH7, potassium voltage-gated channel subfamily H member 7, [RH, Score=841, Expect=0.0]; ENSG00000173826, KCNH6, potassium voltage-gated channel subfamily H member 6, [RH, Score=818, Expect=0.0]; ENSG00000055118, KCNH2, potassium voltage-gated channel subfamily H member 2, [RH, Score=805, Expect=0.0]} {Mouse: ENSMUSG00000059742, Kcnh7, potassium voltage-gated channel, subfamily H (eag-related), member 7, [RH, Score=840, Expect=0.0]; ENSMUSG00000001901, Kcnh6, potassium voltage-gated channel, subfamily H (eag-related), member 6, [RH, Score=816, Expect=0.0]; ENSMUSG00000038319, Kcnh2, potassium voltage-gated channel, subfamily H (eag-related), member 2, [RH, Score=805, Expect=0.0]} {Dmel: FBgn0003353, sei, seizure, [RH, Score=780, Expect=0.0]} {Celegans: WBGene00006830, unc-103, Potassium voltage-gated channel unc-103, [RH, Score=764, Expect=0.0]} {Smed: dd_Smed_v6_12621_0_1, dd_Smed_v6_12621_0_1, [RH, Score=841, Expect=0.0]} {RNA1509_16542} {RNA1310_43827} {RNA815_26448}
21. MligTC455_43084 5 0.11 Mlig455_035337

Neo: -

Age: -

0.979 - - 0.979 - - - Mlig455_035337 {REF} {Length: 1065} {Pfam: Lectin C-type domain [PF00059.23, score=29.5]} {Smed: dd_Smed_v6_38541_0_2, dd_Smed_v6_38541_0_2, [Score=47.0, Expect=2e-06]} {RNA1509_45080} {RNA1310_133134}
22. MligTC455_43829 45 0.95 Mlig455_008872, Mlig455_008973

Neo: -

Age: Down-Up-Up

TLL1 0.979 - - 0.979 - - -

Mlig455_008872 {REF} {Length: 3395} {Pfam: CUB domain [PF00431.22, score=147.6]} {Human: ENSG00000038295, TLL1, tolloid like 1, [Score=92.8, Expect=1e-18]} {Mouse: ENSMUSG00000053626, Tll1, tolloid-like, [Score=91.3, Expect=3e-18]} {Dmel: FBgn0261262, CG42613, [Score=102, Expect=9e-22]} {Celegans: WBGene00002977, lev-10, LEV-10B, [Score=79.0, Expect=9e-15]} {Smed: dd_Smed_v6_19493_0_1, dd_Smed_v6_19493_0_1, [Score=265, Expect=1e-76]} {RNA1509_49507} {RNA1310_6026} {RNA815_27015}

Mlig455_008973 {REF} {Length: 2985} {Pfam: CUB domain [PF00431.22, score=149.2]} {Human: ENSG00000038295, TLL1, tolloid like 1, [Score=90.5, Expect=7e-18]; ENSG00000107611, CUBN, cubilin, [Score=86.3, Expect=2e-16]} {Mouse: ENSMUSG00000053626, Tll1, tolloid-like, [Score=89.0, Expect=2e-17]} {Dmel: FBgn0261262, CG42613, [Score=101, Expect=1e-21]} {Celegans: WBGene00002977, lev-10, LEV-10B, [Score=81.6, Expect=1e-15]} {Smed: dd_Smed_v6_19493_0_1, dd_Smed_v6_19493_0_1, [Score=267, Expect=2e-77]} {RNA1509_49507, RNA1509_572} {RNA1310_6026, RNA1509_49507, RNA1509_572} {RNA1509_49507, RNA1509_572, RNA815_27015}
23. MligTC455_45050 55 1.14 Mlig455_067805

Neo: -

Age: -

ADSL 0.973 - - 0.973 - - - Mlig455_067805 {REF} {Length: 3003} {TRANSSPLICED} {Pfam: Lyase [PF00206.22, score=80.8]} {Human: ENSG00000239900, ADSL, adenylosuccinate lyase, [Score=447, Expect=2e-155]} {Mouse: ENSMUSG00000022407, Adsl, adenylosuccinate lyase, [Score=446, Expect=3e-155]} {Dmel: FBgn0038467, AdSL, Adenylosuccinate Lyase, [Score=431, Expect=1e-148]} {Celegans: WBGene00011064, adsl-1, Adenylosuccinate lyase, [Score=314, Expect=2e-104]} {Smed: dd_Smed_v6_2280_0_1, dd_Smed_v6_2280_0_1, [Score=416, Expect=4e-143]} {RNA1509_16456} {RNA1310_14851} {RNA815_12501}
24. MligTC455_43783 8 0.17 Mlig455_018589

Neo: -

Age: -

0.968 - - 0.968 - - - Mlig455_018589 {REF} {Length: 1005} {Pfam: WSC domain [PF01822.21, score=54.3]}
25. MligTC455_22419 37 0.78 Mlig455_009205

Neo: -

Age: -

0.962 - - - - - 0.962 Mlig455_009205 {REF} {Length: 678} {RNA1310_72808} {RNA815_44140}
26. MligTC455_09573 9 0.18 Mlig455_034666

Neo: -

Age: -

0.958 - - 0.958 - - - Mlig455_034666 {REF} {Length: 444} {NoTransDecoderORF} {RNA1310_102145.2}
27. MligTC455_36895 27 0.57 Mlig455_014066

Neo: -

Age: -

PTK2B 0.955 - - - - 0.955 - Mlig455_014066 {REF} {Length: 7223} {TRANSSPLICED} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=67.4]; Protein kinase domain [PF00069.27, score=27.5]} {Human: ENSG00000120899, PTK2B, protein tyrosine kinase 2 beta, [Score=68.9, Expect=4e-11]; ENSG00000140443, IGF1R, insulin like growth factor 1 receptor, [Score=65.5, Expect=5e-10]} {Mouse: ENSMUSG00000059456, Ptk2b, PTK2 protein tyrosine kinase 2 beta, [Score=69.3, Expect=7e-12]; ENSMUSG00000005533, Igf1r, insulin-like growth factor I receptor, [Score=65.9, Expect=2e-10]} {Dmel: FBgn0264959, Src42A, Src oncogene at 42A, [Score=64.3, Expect=5e-10]} {Celegans: WBGene00000898, daf-2, Insulin-like receptor Insulin-like receptor subunit alpha Insulin-like receptor subunit beta, [Score=63.2, Expect=6e-10]} {Smed: dd_Smed_v6_8651_0_3, dd_Smed_v6_8651_0_3, [Score=70.9, Expect=2e-12]} {RNA1509_5171} {RNA1310_10947.1} {RNA815_402.1}
28. MligTC455_15449 384 7.99 Mlig455_043360

Neo: -

Age: -

0.954 - - 0.954 - - - Mlig455_043360 {REF} {Length: 1602} {NoTransDecoderORF} {RNA1509_38319} {RNA1310_35989.1} {RNA815_36673}
29. MligTC455_23809 119 2.47 Mlig455_065200

Neo: -

Age: -

0.953 - - 0.953 - - - Mlig455_065200 {REF} {Length: 2060} {Pfam: Pacifastin inhibitor (LCMII) [PF05375.15, score=33.7]} {RNA1509_46843} {RNA1310_11232} {RNA815_41042}

Refine r cutoff to:    Show

Berezikov Lab - 2020-2021 © ERIBA